TradingFloor AI · Stock Terminal

LLY - Ticker AI Digest

Eli Lilly and Company 📰 17
US500
1174.61000000 | Today -0.13% ●
Desk Snapshot GO VIP Login
Important AI Risk Notice

Charts, catalyst summaries, AI scores, forecasts and price context are AI-driven and can hallucinate, lag or miss market-changing information.

Not investment advice. Markets can move fast and any trade or allocation decision remains your responsibility.
AI can hallucinate. Summaries, rankings, forecasts and commentary can be wrong, incomplete or misleading.
AI-driven data only. Signals, dates, prices, sentiment and automation outputs may be delayed, estimated or stale.
Always verify externally. Confirm prices, filings, broker notes and trade setup details with independent sources before acting.
Mobile Command Deck
Eli Lilly and Company in one cleaner mobile flow.
Tap straight into the module you want. No sideways tab hunt, just a clean route into charts, news, Today’s AI, and the deeper desks.
LLY Data 2026-08-31 Preview Mode
Core Deck
Deep Dive Modules
Home

Digested News

Today's Catalysts (LLY) 17
LLY 22:28
Eli Lilly and Company
Dow Jones Futures: Oil Prices Keep Rising On Iran News After Samsung Fans AI Fears
LLY 20:29
Eli Lilly and Company
Why Eli Lilly (LLY) Stock Is Trading Up Today
LLY 20:17
Eli Lilly and Company
Eli Lilly (LLY) After The China Verzenios Shift And The Valuation Debate
LLY 19:35
Eli Lilly and Company
Stock Market Today: Nasdaq Is Day's Biggest Loser; Sandisk, Micron Tumble, Eli Lilly Shines
LLY 19:34
Eli Lilly and Company
Dow Jones Futures: Nasdaq Slumps As Samsung Fans AI Fears, Oil Prices Jump On Iran News
LLY 18:51
Eli Lilly and Company
Sector Update: Healthcare Stocks Gain Late Afternoon
LLY 18:28
Eli Lilly and Company
Eli Lilly price target boost, Vertex-Crinetics deal, Meta's new social media lawsuit
LLY 18:22
Eli Lilly and Company
Former Pfizer Building Is Crumbling—Just as the Stock Has
LLY 16:15
Eli Lilly and Company
Eli Lilly's Market Cap Balloons Again On This IPO's Setback
LLY 14:41
Eli Lilly and Company
Kailera falls after late-stage trial data for oral GLP-1 candidate
LLY 13:56
Eli Lilly and Company
CRISPR Therapeutics vs. Viking Therapeutics: Is a Gene-Editing or Weight Loss Focused Stock Is a Better Buy in 2026?
LLY 13:56
Eli Lilly and Company
CRISPR Therapeutics vs. Viking Therapeutics: Is a Gene-Editing or Weight Loss Focused Stock Is a Better Buy in 2026?
LLY 12:43
Eli Lilly and Company
Stock Market Today: Nasdaq Slides As Samsung Tumbles On Earnings; Micron, Sandisk Lose Big (Live Coverage)
LLY 12:01
Eli Lilly and Company
Pfizer or AstraZeneca: Which Stock Offers Better Long-Term Potential?
LLY 11:30
Eli Lilly and Company
Is It Too Late to Buy Eli Lilly Stock? Here's What $1,000 Invested Today Could Be Worth in 10 Years.
LLY 09:23
Eli Lilly and Company
The Zacks Analyst Blog Highlights Eli Lilly, HSBC, Palantir and CBL & Associates
LLY 02:19
Eli Lilly and Company
Eli Lilly (LLY) Expands R And D Reach With Abbisko And China Drug Handover
AI 23
LLY 22:28
Eli Lilly and Company
Dow Jones Futures: Oil Prices Keep Rising On Iran News After Samsung Fans AI Fears
LLY 19:34
Eli Lilly and Company
Dow Jones Futures: Nasdaq Slumps As Samsung Fans AI Fears, Oil Prices Jump On Iran News
LLY 12:20
Eli Lilly and Company
5 Places Investors Can Hide If the AI Trade Keeps Cracking
LLY 21:06
Eli Lilly and Company
Dow Jones Futures Rise With Market At Tipping Point; Iran News, AI Fears In Focus
LLY 18:57
Eli Lilly and Company
Is Eli Lilly and Company (LLY) Among the Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds?
LLY 13:07
Eli Lilly and Company
Is Charles River (CRL) Quietly Redefining Its Moat Through Lilly’s AI-Driven TuneLab Collaboration?
LLY 03:35
Eli Lilly and Company
2 Beaten-Down Artificial Intelligence (AI) Stocks for Contrarian Investors to Consider Buying
LLY 13:30
Eli Lilly and Company
Employers, governments join forces to address AI job loss concerns
LLY 07:50
Eli Lilly and Company
The Next Wave of Medical AI Could Mint More Millionaires Than the First -- Here Are the Stocks to Own
LLY 07:50
Eli Lilly and Company
The Next Wave of Medical AI Could Mint More Millionaires Than the First -- Here Are the Stocks to Own
LLY 12:32
Eli Lilly and Company
Chai Discovery Collaborates with Lilly TuneLab to Offer AI Capabilities to Select Biotechs
LLY 11:00
Eli Lilly and Company
Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise
LLY 04:00
Eli Lilly and Company
Axcelead DDP Joins Lilly TuneLab to Advance AI Drug Discovery
LLY 12:15
Eli Lilly and Company
Wrong-Way AI Trade Costs Florida Stock-Picker $50 Billion
LLY 17:12
Eli Lilly and Company
Eli Lilly’s Abridge Bet Links Healthcare AI To Valuation And Growth
LLY 13:59
Eli Lilly and Company
An AI Price War Is About to Break Out. You Won’t Believe Who Will Profit Most
LLY 18:35
Eli Lilly and Company
Dow Jones AI Giant Nvidia Stock Tumbles To Key Support Level Amid Market Sell-Off
LLY 17:48
Eli Lilly and Company
Deja Vu? AI Overspending Fears Renew
LLY 16:13
Eli Lilly and Company
Stocks Rally as Buyers Return After AI-Led Selloff
LLY 14:45
Eli Lilly and Company
Stocks Push Higher as Chipmakers and AI Companies Rebound
LLY 14:43
Eli Lilly and Company
Top Midday Stories: US Weighs Financial Stakes in AI Firms; Google, Nvidia Turn to Intel as TSMC Struggles With Demand
LLY 14:20
Eli Lilly and Company
Stocks Rally as Buyers Return After AI-Led Selloff
LLY 12:58
Eli Lilly and Company
Stocks Push Higher as Chipmakers and AI Companies Rebound
Acquisitions 5
LLY 12:26
Eli Lilly and Company
Is Eli Lilly and Company (LLY) Strengthening Its Pain Management Strategy With New Biotech Acquisition?
LLY 11:45
Eli Lilly and Company
Lilly completes acquisition of Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
LLY 19:05
Eli Lilly and Company
Acquisition of Centessa by Lilly Approved by the High Court of Justice of England and Wales
LLY 14:05
Eli Lilly and Company
Lilly's 7 Acquisitions in 3 Months: Which Will Be the Biggest Game-Changer for the Pharma Giant?
LLY 14:05
Eli Lilly and Company
Lilly's 7 Acquisitions in 3 Months: Which Will Be the Biggest Game-Changer for the Pharma Giant?
Admission 0
No items for this category on selected date.
Agreement 6
LLY 05:01
Eli Lilly and Company
DKSH Signs Distribution And Promotion Agreement With Eli Lilly And Co In Hong Kong, Macau
LLY 03:00
Eli Lilly and Company
Innovent Biologics and Lilly Enter into Commercialization Agreement for Verzenios® (abemaciclib) in Mainland China
LLY 18:21
Eli Lilly and Company
Eli Lilly (LLY) and BioArctic AB Enter into Research and Collaboration Agreement
LLY 11:05
Eli Lilly and Company
Sangamo Therapeutics Enters Into Asset Sale Agreements with Lilly and Astellas
LLY 05:00
Eli Lilly and Company
BioArctic and Lilly sign research and collaboration agreement combining Lilly compound with BioArctic's BrainTransporter™ technology
LLY 04:30
Eli Lilly and Company
AlzeCure Pharma Enters Into A Collaboration And Out-Licensing Agreement With Lilly For Alzheimer's Project
Approvals 4
LLY 11:30
Eli Lilly and Company
Lilly's Jaypirca Receives Positive CHMP Opinion For EU Approval In Chronic Lymphocytic Leukemia
LLY 10:16
Eli Lilly and Company
Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) across all lines of therapy
LLY 11:37
Eli Lilly and Company
Novo Seeks China Approval for Wegovy Pill
LLY 07:40
Eli Lilly and Company
Market Chatter: Novo Nordisk to Seek China Approval for Oral Wegovy as Obesity Drug
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
BlockListing 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 3
LLY 20:00
Eli Lilly and Company
A $30 Billion Cancer Breakthrough Is Under Threat From Global Conflicts
LLY 11:00
Eli Lilly and Company
Verge Labs Unveils vBx: A Breakthrough Foundation Model for Precision Neurology
LLY 11:45
Eli Lilly and Company
ENDO 2026 Oral Presentation Highlights Comparative Clinical Data for Entera’s Breakthrough Single Tablet EB613 (First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis)
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Circular 0
No items for this category on selected date.
ClinicalTrial 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 1
LLY 11:29
Eli Lilly and Company
Can Amgen's MariTide Win Share in the Fast-Growing Obesity Market?
Covid-19 0
No items for this category on selected date.
Deals 5
LLY 18:28
Eli Lilly and Company
Eli Lilly price target boost, Vertex-Crinetics deal, Meta's new social media lawsuit
LLY 14:42
Eli Lilly and Company
European Stocks Higher in Tuesday Trading; Markets Buoyed by US, Iran Peace Deal; Inflation Remains a Concern
LLY 17:09
Eli Lilly and Company
Eli Lilly Expands Alzheimer’s Pipeline With AlzeCure Deal And Valuation Upside
LLY 15:16
Eli Lilly and Company
Amneal and Pfizer GLP-1 Deal: New Growth Lever?
LLY 09:49
Eli Lilly and Company
Eli Lilly Signs Alzheimer's Licensing Deal Worth Over $1 Billion With AlzeCure
Diamond 0
No items for this category on selected date.
DirectorDealing 0
No items for this category on selected date.
DirectorateChange 0
No items for this category on selected date.
Discovery 1
LLY 12:38
Eli Lilly and Company
AI Is Transforming Drug Discovery. Here Is the Next Trillion-Dollar Biotech Opportunity
Dividend 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 7
LLY 17:47
Eli Lilly and Company
Roche Gets FDA Priority Review for Enspryng in Thyroid Eye Disease
LLY 20:50
Eli Lilly and Company
Eli Lilly, Regeneron named to FDA pilot program to boost US drug manufacturing
LLY 08:09
Eli Lilly and Company
Weekly Buzz: SPRO, ABBV Get FDA Nod, NMRA Halts KOASTAL; ENGN Cuts Jobs; BIIB Acquires RayThera
LLY 15:49
Eli Lilly and Company
FDA Accepts Roche's Filing for Lunsumio VELO-Polivy in LBCL
LLY 20:18
Eli Lilly and Company
FDA Ebglyss Decision Adds New Thread To Eli Lilly Growth Story
LLY 04:01
Eli Lilly and Company
Lilly Receives FDA Nod For EBGLYSS Eight-Week Subcutaneous Maintenance Dose In Atopic Dermatitis
LLY 21:18
Eli Lilly and Company
FDA approves Lilly's EBGLYSS® (lebrikizumab-lbkz) for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis
Form83 0
No items for this category on selected date.
GeneralMeeting 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
IssueOfEquity 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 2
LLY 04:15
Eli Lilly and Company
Top Biotech Gainers: PPCB Launches Share Buyback, VRXA Partners With ATUM, SLS On Watch
LLY 12:30
Eli Lilly and Company
Zepbound (tirzepatide) and Shaquille O'Neal launch national campaign after NBA legend learns the obstructive sleep apnea he has lived with for years is treatable
Litigation 0
No items for this category on selected date.
MonthlyFactsheet 0
No items for this category on selected date.
NAV 0
No items for this category on selected date.
NameChange 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 4
LLY 12:01
Eli Lilly and Company
Pfizer or AstraZeneca: Which Stock Offers Better Long-Term Potential?
LLY 11:59
Eli Lilly and Company
LLY or PFE: Which Drugmaker Offers the Stronger Growth Story?
LLY 09:35
Eli Lilly and Company
Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors
LLY 12:03
Eli Lilly and Company
CVS to offer virtual visits to prescribe GLP-1 weight loss meds
Offtake 0
No items for this category on selected date.
Orders 2
LLY 16:00
Eli Lilly and Company
Alcohol Use Disorder Market Set to Expand at a 12.1% CAGR During the Forecast Period (2026–2036), Owing to the Emergence of Novel Mechanisms Such as 5-HT3 Pathway, NOP Receptor, mGluR5 NAM, and Other | DelveInsight
LLY 16:00
Eli Lilly and Company
Alcohol Use Disorder Market Set to Expand at a 12.1% CAGR During the Forecast Period (2026–2036), Owing to the Emergence of Novel Mechanisms Such as 5-HT3 Pathway, NOP Receptor, mGluR5 NAM, and Other | DelveInsight
OwnShares 0
No items for this category on selected date.
Partner 1
LLY 14:16
Eli Lilly and Company
Abridge CEO Dr. Shiv Rao Elaborates on New Partnerships with Eli Lilly + Nvidia
Patents 0
No items for this category on selected date.
Placing 2
LLY 07:52
Eli Lilly and Company
ProQR Prices Direct Offering And Private Placement For $59 Mln In Gross Proceeds; Stock Falls 20%
LLY 09:35
Eli Lilly and Company
ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement
Positive 0
No items for this category on selected date.
ProfitWarning 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Prospectus 0
No items for this category on selected date.
Reports 13
LLY 19:26
Eli Lilly and Company
Top Stock Reports for Eli Lilly, HSBC & Palantir
LLY 07:30
Eli Lilly and Company
[Latest] Global Antidiabetic Drugs Market Size/Share Worth USD 309.84 Billion by 2035 at a 11.62% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
LLY 12:05
Eli Lilly and Company
Novo reportedly seeking discounts from suppliers to cut costs
LLY 14:38
Eli Lilly and Company
Pivotal Week Ahead: Warsh's Hawkish Turn, June Jobs Report on Deck
LLY 14:26
Eli Lilly and Company
Nike Stock Languishes, But Looming Earnings Report Fuels Turnaround Optimism
LLY 14:18
Eli Lilly and Company
FDA commissioner contenders down to three - report
LLY 14:56
Eli Lilly and Company
Daily Dividend Report: ABBV,WKC,OC,DAL,LLY,DTE
LLY 21:30
Eli Lilly and Company
[Latest] Global GLP-1 Receptor Agonist Market Size/Share Worth USD 95.3 Billion by 2035 at a 12.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
LLY 14:37
Eli Lilly and Company
Eli Lilly (LLY) Moves to Enforce 340B Claims Data Reporting Compliance
LLY 10:04
Eli Lilly and Company
HTX Releases May Performance Report: TradFi Monthly Trading Volume Surpasses $1 Billion, While Multi-Front Progress Rebuilds Ecosystem Confidence
LLY 17:25
Eli Lilly and Company
Novo’s Wegovy pill reportedly generates 10,000-patient waiting list in U.K.
LLY 22:21
Eli Lilly and Company
Eli Lilly (LLY) Reports Positive Foundayo Weight Loss Data for Menopausal Women
LLY 19:07
Eli Lilly and Company
Sciwind Reports 12.8% Weight Loss As Global Expansion Talks Deepen
Results 5
LLY 13:50
Eli Lilly and Company
Will Immunology Franchise Aid AbbVie's Upcoming Q2 Results?
LLY 13:23
Eli Lilly and Company
Eli Lilly Hits Highs on GLP-1 Medicare Inclusion, Huge Results
LLY 10:21
Eli Lilly and Company
Eli Lilly (LLY) Announces Positive Phase 3 Results for Jaypirca Combination in Relapsed CLL/SLL
LLY 14:13
Eli Lilly and Company
Campbell's Earnings Beat; Eli Lilly Obesity Drug Results | Stock Movers
LLY 09:16
Eli Lilly and Company
Lilly's Retatrutide Delivers Landmark Phase 3 Results Across Obesity And Related Conditions
SchemeOfArrangement 0
No items for this category on selected date.
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 0
No items for this category on selected date.
TVR 0
No items for this category on selected date.
Takeover 0
No items for this category on selected date.
US News 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 15
LLY 18:51
Eli Lilly and Company
Sector Update: Healthcare Stocks Gain Late Afternoon
LLY 19:20
Eli Lilly and Company
Eli Lilly Upgraded, Carvana Downgraded: Updated Rankings on Top Blue-Chip Stocks
LLY 18:42
Eli Lilly and Company
Sector Update: Healthcare Stocks Gain Late Afternoon
LLY 18:48
Eli Lilly and Company
Sector Update: Healthcare Stocks Gain Late Afternoon
LLY 18:32
Eli Lilly and Company
Sector Update: Healthcare Stocks Advance Late Afternoon
LLY 11:55
Eli Lilly and Company
NYSE Content Update: Abridge Partners with Eli Lilly, Nvidia to Improve Healthcare
LLY 11:55
Eli Lilly and Company
NYSE Content Update: Abridge Partners with Eli Lilly, Nvidia to Improve Healthcare
LLY 16:38
Eli Lilly and Company
Sector Update: Healthcare Stocks Advance in Afternoon Trading
LLY 16:29
Eli Lilly and Company
Sector Update: Healthcare Stocks Advance in Afternoon Trading
LLY 12:51
Eli Lilly and Company
Verizon Upgraded, Oracle Downgraded: Updated Rankings on Top Blue-Chip Stocks
LLY 12:05
Eli Lilly and Company
Update: Market Chatter: Some US Employers Plan to Drop GLP-1 Coverage for Obesity in 2027
LLY 09:35
Eli Lilly and Company
AbbVie Reports Promising New Clinical Updates. Here's What It Means for the Company's Dividend.
LLY 18:28
Eli Lilly and Company
Sector Update: Healthcare Stocks Higher Late Afternoon
LLY 18:43
Eli Lilly and Company
Sector Update: Healthcare Stocks Rise Late Afternoon
LLY 18:48
Eli Lilly and Company
Sector Update: Healthcare Stocks Decline Late Afternoon
Vaccine 1
LLY 03:19
Eli Lilly and Company
Eli Lilly Expands Beyond Obesity With US$4b Vaccine And Genetic Bets
Wins 4
LLY 11:08
Eli Lilly and Company
Eli Lilly (LLY) Wins EMA Backing For Jaypirca In Chronic Lymphocytic Leukemia
LLY 13:56
Eli Lilly and Company
Eli Lilly Wins FDA Nod for Extended Ebglyss Dosing in Eczema Care
LLY 10:00
Eli Lilly and Company
Eli Lilly wins FDA nod for eight-week dosing regimen of eczema therapy Ebglyss
LLY 09:17
Eli Lilly and Company
Eli Lilly Obesity Wins Recast Retatrutide And Foundayo As Cardiometabolic Story
Worth 6
LLY 11:30
Eli Lilly and Company
Is It Too Late to Buy Eli Lilly Stock? Here's What $1,000 Invested Today Could Be Worth in 10 Years.
LLY 04:25
Eli Lilly and Company
How Much Could $1,000 Invested in Viking Therapeutics Be Worth by 2030?
LLY 11:30
Eli Lilly and Company
Here's How Much a $1000 Investment in Eli Lilly Made 10 Years Ago Would Be Worth Today
LLY 19:02
Eli Lilly and Company
Noteworthy Thursday Option Activity: LLY, AMD, PZZA
LLY 17:20
Eli Lilly and Company
Noteworthy Wednesday Option Activity: LLY, JNJ, CASY
LLY 14:53
Eli Lilly and Company
Is Altimmune Worth Buying Ahead of 2026 Catalysts?
All Market News (Last 30 Days) 200
LLY 22:28
Eli Lilly and Company
Dow Jones Futures: Oil Prices Keep Rising On Iran News After Samsung Fans AI Fears
LLY 20:29
Eli Lilly and Company
Why Eli Lilly (LLY) Stock Is Trading Up Today
LLY 20:17
Eli Lilly and Company
Eli Lilly (LLY) After The China Verzenios Shift And The Valuation Debate
LLY 19:35
Eli Lilly and Company
Stock Market Today: Nasdaq Is Day's Biggest Loser; Sandisk, Micron Tumble, Eli Lilly Shines
LLY 19:34
Eli Lilly and Company
Dow Jones Futures: Nasdaq Slumps As Samsung Fans AI Fears, Oil Prices Jump On Iran News
LLY 18:51
Eli Lilly and Company
Sector Update: Healthcare Stocks Gain Late Afternoon
LLY 18:28
Eli Lilly and Company
Eli Lilly price target boost, Vertex-Crinetics deal, Meta's new social media lawsuit
LLY 18:22
Eli Lilly and Company
Former Pfizer Building Is Crumbling—Just as the Stock Has
LLY 16:15
Eli Lilly and Company
Eli Lilly's Market Cap Balloons Again On This IPO's Setback
LLY 14:41
Eli Lilly and Company
Kailera falls after late-stage trial data for oral GLP-1 candidate
LLY 13:56
Eli Lilly and Company
CRISPR Therapeutics vs. Viking Therapeutics: Is a Gene-Editing or Weight Loss Focused Stock Is a Better Buy in 2026?
LLY 13:56
Eli Lilly and Company
CRISPR Therapeutics vs. Viking Therapeutics: Is a Gene-Editing or Weight Loss Focused Stock Is a Better Buy in 2026?
LLY 12:43
Eli Lilly and Company
Stock Market Today: Nasdaq Slides As Samsung Tumbles On Earnings; Micron, Sandisk Lose Big (Live Coverage)
LLY 12:01
Eli Lilly and Company
Pfizer or AstraZeneca: Which Stock Offers Better Long-Term Potential?
LLY 11:30
Eli Lilly and Company
Is It Too Late to Buy Eli Lilly Stock? Here's What $1,000 Invested Today Could Be Worth in 10 Years.
LLY 09:23
Eli Lilly and Company
The Zacks Analyst Blog Highlights Eli Lilly, HSBC, Palantir and CBL & Associates
LLY 02:19
Eli Lilly and Company
Eli Lilly (LLY) Expands R And D Reach With Abbisko And China Drug Handover
LLY 20:45
Eli Lilly and Company
Eli Lilly (LLY) Stock Slides as Market Rises: Facts to Know Before You Trade
LLY 19:26
Eli Lilly and Company
Top Stock Reports for Eli Lilly, HSBC & Palantir
LLY 17:04
Eli Lilly and Company
3 Healthcare ETFs to Own in a Choppy Stock Market
LLY 16:29
Eli Lilly and Company
Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?
LLY 16:29
Eli Lilly and Company
Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?
LLY 14:57
Eli Lilly and Company
Lilly, This IPO Leader Among Stocks To Watch In A Mischievous Market
LLY 14:41
Eli Lilly and Company
Johnson & Johnson, IBD Stock Of The Day, In Buy Zone Heading Into Earnings
LLY 14:12
Eli Lilly and Company
Abivax Rebounds, but Obefazimod Unlikely to Replace JAK Inhibitors, Wedbush Says
LLY 13:50
Eli Lilly and Company
Will Immunology Franchise Aid AbbVie's Upcoming Q2 Results?
LLY 13:39
Eli Lilly and Company
Eli Lilly and Company (LLY) Fell on Regulatory And Pricing Policy Challenges
LLY 12:00
Eli Lilly and Company
Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know
LLY 10:35
Eli Lilly and Company
Could This Healthcare Stock Help You Build a Real Fortune Over the Next 20 Years?
LLY 10:35
Eli Lilly and Company
Could This Healthcare Stock Help You Build a Real Fortune Over the Next 20 Years?
LLY 08:30
Eli Lilly and Company
Could Buying Eli Lilly Stock Today Set You Up for Life? (Hint: Yes.)
LLY 05:01
Eli Lilly and Company
DKSH Signs Distribution And Promotion Agreement With Eli Lilly And Co In Hong Kong, Macau
LLY 17:37
Eli Lilly and Company
Citi's picks and pans for H2 '26: REITs, tech, consumer, health
LLY 14:36
Eli Lilly and Company
IHE vs. PJP: Which Pharmaceutical ETF Is the Better Buy for Investors?
LLY 12:35
Eli Lilly and Company
Fidelity Health Care vs. State Street Biotech: Which ETF Fits Your Portfolio Best?
LLY 12:35
Eli Lilly and Company
Fidelity Health Care vs. State Street Biotech: Which ETF Fits Your Portfolio Best?
LLY 12:05
Eli Lilly and Company
Notable healthcare headlines for the week: Abbott, AstraZeneca, and Eli Lilly in focus
LLY 04:25
Eli Lilly and Company
How Much Could $1,000 Invested in Viking Therapeutics Be Worth by 2030?
LLY 02:16
Eli Lilly and Company
Eli Lilly (LLY) Stock May Trade At A Cash Flow Discount But An Earnings Premium
LLY 19:31
Eli Lilly and Company
Which Pharmaceutical ETF Is Better, VanEck's PPH or Invesco's PJP?
LLY 19:31
Eli Lilly and Company
Which Pharmaceutical ETF Is Better, VanEck's PPH or Invesco's PJP?
LLY 18:37
Eli Lilly and Company
The Smartest Vanguard ETF to Buy With $1,000 Right Now
LLY 17:00
Eli Lilly and Company
Dividend King vs. Growth Giant: Johnson & Johnson Takes on Eli Lilly
LLY 15:05
Eli Lilly and Company
State Street Health Care ETF Tops Invesco Pharma on Cost and Size
LLY 15:05
Eli Lilly and Company
State Street Health Care ETF Tops Invesco Pharma on Cost and Size
LLY 12:35
Eli Lilly and Company
Vanguard Health Care vs. iShares Biotech: How Do These ETFs Stack Up?
LLY 10:06
Eli Lilly and Company
FHLC vs. BBH: Which Healthcare ETF Is the Better Buy?
LLY 08:30
Eli Lilly and Company
Is Viking Therapeutics Stock Going to $50? Here's What the Bulls and Bears Are Saying
LLY 00:35
Eli Lilly and Company
Johnson & Johnson Is Walking Away From a $100 Billion Obesity Market. Could That Actually Make It the Better Long-Term Buy Than Eli Lilly?
LLY 00:35
Eli Lilly and Company
Johnson & Johnson Is Walking Away From a $100 Billion Obesity Market. Could That Actually Make It the Better Long-Term Buy Than Eli Lilly?
LLY 12:45
Eli Lilly and Company
Here's Why Viking Therapeutics Stock Surged Higher in June
LLY 12:45
Eli Lilly and Company
Here's Why Viking Therapeutics Stock Surged Higher in June
LLY 12:12
Eli Lilly and Company
Can Medicare Bridge Help Novo Nordisk Defend Its GLP-1 Leadership?
LLY 07:30
Eli Lilly and Company
[Latest] Global Antidiabetic Drugs Market Size/Share Worth USD 309.84 Billion by 2035 at a 11.62% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
LLY 04:15
Eli Lilly and Company
Top Biotech Gainers: PPCB Launches Share Buyback, VRXA Partners With ATUM, SLS On Watch
LLY 16:29
Eli Lilly and Company
JNJ Stock Management Sees A Breakout, The Market Sees A Standoff
LLY 15:07
Eli Lilly and Company
Healthcare Stocks Rise To The Heart Of IBD's Elite List Of Growth Names
LLY 12:05
Eli Lilly and Company
Novo reportedly seeking discounts from suppliers to cut costs
LLY 11:49
Eli Lilly and Company
Lilly Up Around 7% in a Week: Should You Buy, Sell or Hold the Stock?
LLY 11:05
Eli Lilly and Company
SPDR Health Care ETF Tops iShares Biotech in Long-Term Returns
LLY 20:33
Eli Lilly and Company
Is Eli Lilly (LLY) One of Billionaire Cliff Asness’ Best Healthcare Stock Picks ?
LLY 16:18
Eli Lilly and Company
Eli Lilly Price Prediction: The Case for Double-Digit Upside
LLY 15:41
Eli Lilly and Company
Branded Pharmaceuticals Stocks Q1 Teardown: Zoetis (NYSE:ZTS) Vs The Rest
LLY 14:50
Eli Lilly and Company
New Nancy Pelosi? Senator Ashley Moody Up 310% in One Year With These Stocks
LLY 13:23
Eli Lilly and Company
Eli Lilly Hits Highs on GLP-1 Medicare Inclusion, Huge Results
LLY 12:17
Eli Lilly and Company
Eli Lilly (LLY) Faces China Trial Security Probe From U.S. Lawmakers
LLY 12:05
Eli Lilly and Company
A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity
LLY 12:04
Eli Lilly and Company
Amgen or Biogen: Which Biotech Stock Appears Better Poised?
LLY 11:34
Eli Lilly and Company
Zacks Investment Ideas feature highlights: Eli Lilly and Altria
LLY 11:13
Eli Lilly and Company
Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 Coverage
LLY 11:00
Eli Lilly and Company
ARTAN Bio Closes $1 Million Seed Round to Advance its tRNA Platform Toward Human Studies
LLY 19:03
Eli Lilly and Company
Medicare GLP-1 Bridge Program Will Pay for Novo, Lilly Drugs
LLY 17:47
Eli Lilly and Company
Roche Gets FDA Priority Review for Enspryng in Thyroid Eye Disease
LLY 16:02
Eli Lilly and Company
Eli Lilly Hands China Sales Rights for Verzenio to Innovent
LLY 14:38
Eli Lilly and Company
Pivotal Week Ahead: Warsh's Hawkish Turn, June Jobs Report on Deck
LLY 13:22
Eli Lilly and Company
Can Eli Lilly's New Drugs Fuel Growth Beyond Its GLP-1 Blockbusters?
LLY 12:38
Eli Lilly and Company
AI Is Transforming Drug Discovery. Here Is the Next Trillion-Dollar Biotech Opportunity
LLY 12:00
Eli Lilly and Company
TRexBio Announces Pipeline Progress, Naming TRB-071 as a CD30 Agonist for Immune-Mediated Diseases and Advancement of Lilly-Partnered TRB-051
LLY 11:57
Eli Lilly and Company
Innovent And Lilly Join Forces To Broaden Verzenios Reach In China
LLY 11:14
Eli Lilly and Company
Eli Lilly Expands China Cancer Reach
LLY 11:14
Eli Lilly and Company
Apple Supplier Leak Exposes iPhone 18 Details
LLY 11:00
Eli Lilly and Company
Flare Therapeutics Secures $85M in Insider-Led Series C Financing and Appoints Anna Protopapas as Chief Executive Officer
LLY 08:50
Eli Lilly and Company
3 Magnificent Dividend ETFs That Could Supercharge Your Passive Income
LLY 08:26
Eli Lilly and Company
Ranking Wall Street's Trillion-Dollar Stocks From Most to Least Attractive, Based on Future Cash Flow
LLY 07:22
Eli Lilly and Company
5 Reasons Eli Lilly Is a Better Stock to Buy Right Now Than SpaceX
LLY 07:22
Eli Lilly and Company
5 Reasons Eli Lilly Is a Better Stock to Buy Right Now Than SpaceX
LLY 03:46
Eli Lilly and Company
Big Pharma Has a Case of Merger Mania
LLY 03:00
Eli Lilly and Company
Innovent Biologics and Lilly Enter into Commercialization Agreement for Verzenios® (abemaciclib) in Mainland China
LLY 20:50
Eli Lilly and Company
Eli Lilly, Regeneron named to FDA pilot program to boost US drug manufacturing
LLY 20:45
Eli Lilly and Company
Eli Lilly (LLY) Outpaces Stock Market Gains: What You Should Know
LLY 19:20
Eli Lilly and Company
Eli Lilly Upgraded, Carvana Downgraded: Updated Rankings on Top Blue-Chip Stocks
LLY 17:33
Eli Lilly and Company
AbbVie Stock Rockets 17% With 5-Day Winning Streak
LLY 16:37
Eli Lilly and Company
Should You Chase The Breakout In Eli Lilly Stock?
LLY 14:10
Eli Lilly and Company
Biotech Bigwigs ABBV, JNJ, BIIB & LLY Hit New 52-Week Highs
LLY 14:10
Eli Lilly and Company
Novo Nordisk vs. Viking: Which Obesity Drug Stock Is the Better Buy?
LLY 12:28
Eli Lilly and Company
Stock Market News for Jun 29, 2026
LLY 12:27
Eli Lilly and Company
Here's Why Shares of Eli Lilly Hit an All-Time High on Friday
LLY 12:20
Eli Lilly and Company
5 Places Investors Can Hide If the AI Trade Keeps Cracking
LLY 11:30
Eli Lilly and Company
Here's How Much a $1000 Investment in Eli Lilly Made 10 Years Ago Would Be Worth Today
LLY 10:46
Eli Lilly and Company
Lilly (LLY) Moves 7.1% Higher: Will This Strength Last?
LLY 09:15
Eli Lilly and Company
3 Monster Stocks to Buy Right Now With Dividend Yields of 5% or More
LLY 08:30
Eli Lilly and Company
2 Top Growth Stocks to Buy Right Now Without Hesitation
LLY 08:30
Eli Lilly and Company
2 Top Growth Stocks to Buy Right Now Without Hesitation
LLY 08:04
Eli Lilly and Company
Will SpaceX Stock Double Anytime Soon? No -- but These 3 Stocks Could
LLY 08:04
Eli Lilly and Company
Will SpaceX Stock Double Anytime Soon? No -- but These 3 Stocks Could
LLY 06:55
Eli Lilly and Company
Eli Lilly and Company (LLY) Up More Than 6% Over the Past Month, Can it Move Higher?
LLY 00:27
Eli Lilly and Company
Harbour BioMed Appoints Dr. Lloyd Klickstein as Scientific Advisor for Immunology
LLY 21:18
Eli Lilly and Company
Dow Jones Futures Rise On U.S.-Iran News; Market At Tipping Point
LLY 21:06
Eli Lilly and Company
Dow Jones Futures Rise With Market At Tipping Point; Iran News, AI Fears In Focus
LLY 18:57
Eli Lilly and Company
Is Eli Lilly and Company (LLY) Among the Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds?
LLY 12:05
Eli Lilly and Company
Notable healthcare headlines for the week: Merck, AbbVie, and Bayer in focus
LLY 18:35
Eli Lilly and Company
Opinion: Pfizer Is a Fantastic Dividend Stock for Income Investors to Buy Right Now
LLY 18:35
Eli Lilly and Company
Opinion: Pfizer Is a Fantastic Dividend Stock for Income Investors to Buy Right Now
LLY 18:21
Eli Lilly and Company
Eli Lilly (LLY) and BioArctic AB Enter into Research and Collaboration Agreement
LLY 17:36
Eli Lilly and Company
Here’s What the Street Thinks About Eli Lilly and Company (LLY)
LLY 11:08
Eli Lilly and Company
Eli Lilly (LLY) Wins EMA Backing For Jaypirca In Chronic Lymphocytic Leukemia
LLY 11:00
Eli Lilly and Company
Eli Lilly Leads 5 Stocks Near Buy Points As The Market Rally Rotates
LLY 10:21
Eli Lilly and Company
Eli Lilly (LLY) Announces Positive Phase 3 Results for Jaypirca Combination in Relapsed CLL/SLL
LLY 23:40
Eli Lilly and Company
Revealed! 3 Undervalued Stocks I Just Bought
LLY 23:35
Eli Lilly and Company
Is Eli Lilly Stock an Undervalued Healthcare Stock to Buy?
LLY 22:34
Eli Lilly and Company
Why Eli Lilly Stock Jumped to a New All-Time High Today
LLY 22:34
Eli Lilly and Company
Why Eli Lilly Stock Jumped to a New All-Time High Today
LLY 21:24
Eli Lilly and Company
Why Is Eli Lilly (LLY) Stock Soaring Today
LLY 19:55
Eli Lilly and Company
Dow Jones Futures: Market At Tipping Point, Here's What To Do. Eli Lilly Soars, Tesla On Tap.
LLY 19:39
Eli Lilly and Company
Heatmap Highlights: Tech rotation, defensive surge shape S&P 500
LLY 18:42
Eli Lilly and Company
Sector Update: Healthcare Stocks Gain Late Afternoon
LLY 17:39
Eli Lilly and Company
Investing.com’s stocks of the week
LLY 16:49
Eli Lilly and Company
Lilly, J&J and AbbVie Hit New Highs
LLY 16:46
Eli Lilly and Company
Emerging-Market Stocks Sink 3.9% as Tech Selloff Hits Asia
LLY 16:46
Eli Lilly and Company
Apple Suffers Worst Drop in Over a Year
LLY 16:23
Eli Lilly and Company
Snap’s Specs Gamble
LLY 15:22
Eli Lilly and Company
Lilly, J&J, AbbVie hit new 52-week highs as healthcare outperforms
LLY 15:03
Eli Lilly and Company
AbbVie Stock's Growth Story Has One Question Mark
LLY 14:36
Eli Lilly and Company
Why Moderna Stock Is Soaring and Leading the S&P 500 Today
LLY 14:26
Eli Lilly and Company
Nike Stock Languishes, But Looming Earnings Report Fuels Turnaround Optimism
LLY 14:22
Eli Lilly and Company
Acadia rises as EU backs Rett syndrome therapy
LLY 14:22
Eli Lilly and Company
Trump name-dropped Nokia and Eli Lilly in a Pennsylvania speech. Here's what happened to 5 other stocks he singled out
LLY 14:18
Eli Lilly and Company
FDA commissioner contenders down to three - report
LLY 13:11
Eli Lilly and Company
Medicare GLP-1 Bridge: What to expect
LLY 13:07
Eli Lilly and Company
Is Charles River (CRL) Quietly Redefining Its Moat Through Lilly’s AI-Driven TuneLab Collaboration?
LLY 11:30
Eli Lilly and Company
Lilly's Jaypirca Receives Positive CHMP Opinion For EU Approval In Chronic Lymphocytic Leukemia
LLY 10:40
Eli Lilly and Company
Fidelity (FHLC) vs. iShares (IXJ): Which Healthcare ETF Delivers Better Value?
LLY 10:16
Eli Lilly and Company
Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) across all lines of therapy
LLY 07:52
Eli Lilly and Company
ProQR Prices Direct Offering And Private Placement For $59 Mln In Gross Proceeds; Stock Falls 20%
LLY 07:06
Eli Lilly and Company
Absci (ABSI) Is Up 37.8% After ABS-201 Data And Equity Raise - Has The Bull Case Changed?
LLY 07:06
Eli Lilly and Company
Eli Lilly (LLY) Acquires Centessa Pharmaceuticals to Advance Orexin Receptor 2 Agonists
LLY 03:35
Eli Lilly and Company
2 Beaten-Down Artificial Intelligence (AI) Stocks for Contrarian Investors to Consider Buying
LLY 01:31
Eli Lilly and Company
Nancy Pelosi Stock Tracker Flags Eli Lilly, Nokia After Trump Praise: ‘Keep An Eye On These Two’
LLY 19:02
Eli Lilly and Company
Noteworthy Thursday Option Activity: LLY, AMD, PZZA
LLY 18:48
Eli Lilly and Company
Sector Update: Healthcare Stocks Gain Late Afternoon
LLY 14:38
Eli Lilly and Company
An Analyst Just Declared Eli Lilly the "Clear Winner" of an American Diabetes Association Conference Focused on Weight-Loss Drugs. Novo's Chief Scientist Disagrees. Who's Right?
LLY 13:30
Eli Lilly and Company
Employers, governments join forces to address AI job loss concerns
LLY 12:57
Eli Lilly and Company
VKTX Stock Jumps on Phase I Study Initiation for New Obesity Drug
LLY 12:40
Eli Lilly and Company
Nike Joins Alphabet, Walmart in Hiring a CFO From the Outside
LLY 12:34
Eli Lilly and Company
Novartis Eyes $5 Billion Pluvicto Opportunity
LLY 09:45
Eli Lilly and Company
What Medicare Part D patients need to know about accessing Foundayo (orforglipron) and Zepbound (tirzepatide) for weight management
LLY 09:35
Eli Lilly and Company
ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement
LLY 05:20
Eli Lilly and Company
The Artificial Intelligence Opportunity Beyond Big Tech: 3 Healthcare Stocks to Watch
LLY 03:16
Eli Lilly and Company
Eli Lilly and Company (LLY) – Among the 10 Reliable Dividend Stocks to Buy for Long-Term Investors
LLY 00:15
Eli Lilly and Company
The Bull Case For Eli Lilly (LLY) Could Change Following New Multi‑Target R&D Alliances With Biotechs
LLY 20:00
Eli Lilly and Company
A $30 Billion Cancer Breakthrough Is Under Threat From Global Conflicts
LLY 18:32
Eli Lilly and Company
Sector Update: Healthcare Stocks Advance Late Afternoon
LLY 17:56
Eli Lilly and Company
Why Illumina (ILMN) Stock Is Trading Up Today
LLY 17:47
Eli Lilly and Company
J&J CEO sends a clear message on the obesity drug boom
LLY 15:23
Eli Lilly and Company
US decries the 'free ride' countries with public health systems are getting by negotiating deals for prescription drugs
LLY 14:16
Eli Lilly and Company
Abridge CEO Dr. Shiv Rao Elaborates on New Partnerships with Eli Lilly + Nvidia
LLY 12:26
Eli Lilly and Company
Is Eli Lilly and Company (LLY) Strengthening Its Pain Management Strategy With New Biotech Acquisition?
LLY 11:59
Eli Lilly and Company
LLY or PFE: Which Drugmaker Offers the Stronger Growth Story?
LLY 11:55
Eli Lilly and Company
NYSE Content Update: Abridge Partners with Eli Lilly, Nvidia to Improve Healthcare
LLY 11:55
Eli Lilly and Company
NYSE Content Update: Abridge Partners with Eli Lilly, Nvidia to Improve Healthcare
LLY 11:45
Eli Lilly and Company
Lilly completes acquisition of Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
LLY 10:25
Eli Lilly and Company
Absci surges on Eli Lilly, private equity investments
LLY 09:35
Eli Lilly and Company
Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors
LLY 09:20
Eli Lilly and Company
Should You Invest in the iShares U.S. Healthcare ETF (IYH)?
LLY 09:19
Eli Lilly and Company
Market Chatter: Eli Lilly, Bayer Back US Campaign to Increase Drug Prices in Europe
LLY 09:03
Eli Lilly and Company
The Vanguard ETF That Could Set You Up for Life if You Buy It Today
LLY 09:03
Eli Lilly and Company
The Vanguard ETF That Could Set You Up for Life if You Buy It Today
LLY 08:00
Eli Lilly and Company
Recent pharma exec shake-ups signal strategic shifts
LLY 07:28
Eli Lilly and Company
Zacks Investment Ideas feature highlights: IBB, Novartis, Pfizer and Eli Lilly's
LLY 00:12
Eli Lilly and Company
Adding Eli Lilly’s R&D Chief to the Board Might Change The Case For Investing In Illumina (ILMN)
LLY 00:00
Eli Lilly and Company
Abbisko Therapeutics Deepens R&D Collaboration with Lilly
LLY 19:17
Eli Lilly and Company
Biotech's Silent Resurgence (5-Year Base Breakout)
LLY 18:55
Eli Lilly and Company
UPS is shelling out nearly $50 million on temperature-controlled facilities to meet the booming demand for GLP-1 deliveries
LLY 18:55
Eli Lilly and Company
Eli Lilly and Company (LLY) CEO on How GLP-1s Will Reshape America
LLY 16:38
Eli Lilly and Company
Sector Update: Healthcare Stocks Advance in Afternoon Trading
LLY 16:23
Eli Lilly and Company
Nvidia Targets a $300 Billion Pharma Market
LLY 16:03
Eli Lilly and Company
How Eli Lilly's CEO Plans to Defeat Pharma's Boom-Bust Cycle
LLY 15:50
Eli Lilly and Company
Lilly Drug Access Draws Attention
LLY 14:52
Eli Lilly and Company
Branded Pharmaceuticals Stocks Q1 Teardown: Supernus Pharmaceuticals (NASDAQ:SUPN) Vs The Rest
LLY 13:34
Eli Lilly and Company
Eli Lilly vs Viking Therapeutics: Which GLP-1 Stock Is the Better Buy?
LLY 12:05
Eli Lilly and Company
Daniel M. Skovronsky, MD, PhD, appointed to Illumina's Board of Directors
LLY 12:00
Eli Lilly and Company
Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock
LLY 12:00
Eli Lilly and Company
ŌURA and LillyDirect to Expand Support for People Using GLP-1 Therapies with New Tools and Savings Options
LLY 11:05
Eli Lilly and Company
Sangamo Therapeutics Enters Into Asset Sale Agreements with Lilly and Astellas
LLY 08:37
Eli Lilly and Company
TRIMTECH Therapeutics Brings Total Seed Round to $47M with Additional Investment of $14M to Further Develop TRIMTAC and TRIMGLUE Targeted Protein Degradation Portfolio
LLY 06:05
Eli Lilly and Company
2 Underrated Weight Loss Stocks to Buy and Hold
LLY 00:16
Eli Lilly and Company
Eli Lilly (LLY) Taps BioArctic As Dealmaking Push Broadens Its Pipeline
LLY 23:35
Eli Lilly and Company
Why This Mid-Cap Biotech Could Be the Dark-Horse Threat to Eli Lilly and Novo Nordisk
LLY 19:53
Eli Lilly and Company
The $11 Billion Reason Abbvie Stock Is Up Today
LLY 19:05
Eli Lilly and Company
Acquisition of Centessa by Lilly Approved by the High Court of Justice of England and Wales

Today's AI

LLY · Agentic Market Intelligence

LLY intelligence is listening.

The engine is monitoring news, price structure, forecasts and financial changes. New scored evidence will appear here against this stock automatically.

Live catalyst scoringAI price pathsRisk-aware triggersFinancial blend
AI bias0.0
Bullish0
Bearish0
Today's AI Starts With News

17 live catalysts is opening Today’s AI for LLY.

Start with the live headline tape first. Today’s AI findings sit next, and the AI Blend stack drops lower once the news context is framed. Financial Forecastist now feeds the blend too.
Live Tape Data 2026-08-31 Blend Lower Down
Read the alert tape first, then open Today’s AI findings. Use AI Expand on any card to open the AI explanation, results tables and financial forecast rows instantly.
17 Today
Front Of Desk
Eli Lilly and Company has fresh news flow live now, so Today’s AI is leading with the tape before the blended signal stack below.
22:28 Today's Catalyst Dow Jones Futures: Oil Prices Keep Rising On Iran News After Samsung Fans AI Fears 20:29 Today's Catalyst Why Eli Lilly (LLY) Stock Is Trading Up Today 20:17 Today's Catalyst Eli Lilly (LLY) After The China Verzenios Shift And The Valuation Debate
+14 more headlines waiting in Digested News
Single-Ticker Today's AI
LLY signal theatre built from scored market catalysts, automated AI forecasts, financial forecasting and live trigger logic.

This is the ticker-specific Today’s AI desk for Eli Lilly and Company. It compresses the live catalyst tape, bullish and bearish scoring, AI price forecasts, financial forecasting and trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI + Financial Blend Buy / Sell Trigger Engine Today's AI Findings
Create Account Member Login
Subscriber Unlock
Subscribe to unlock the full LLY Today’s AI cockpit.

Subscription turns this tab into a live signal desk with today’s news findings at the top, AI plus financial blend comparisons at the bottom, buy and sell trigger logic, and the full findings ledger behind every scored row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific Today’s AI stack, sentiment gauges, AI blend stage, and the full findings ledger for LLY on 2026-08-31.

Fundamentals Matrix

About Eli Lilly and Company
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, such as Cyramza for the second-line treatment of gastric cancer or gastro-esophageal junction adenocarcinoma; Erbitux for colorectal cancers and head and neck cancers; Inluriyo for breast cancer; Jaypirca for chronic lymphocytic leukemia or small lymphocytic lymphoma; Retevmo for the treatment of metastatic NSCLC; TYVYT for classic hodgkin's lymphoma; and Verzenio for breast cancer. In addition, the company offers immunology products, which include Ebglyss for severe atopic dermatitis; Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Omvoh for ulcerative colitis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. Further, it provides Emgality for migraine prevention and episodic cluster headache, as well as Kisubla for symptomatic Alzheimer's disease. The company has collaborations with Boehringer Ingelheim Pharmaceuticals, Inc. for the Jardiance product family; and F. Hoffmann-La Roche Ltd and Genentech, Inc. for lebrikizumab, as well as license agreements with Almirall, S.A. for Ebglyss; and Chugai Pharmaceutical Co., Ltd for orforglipron; strategic collaboration with Ascidian Therapeutics for development of therapies for undisclosed monogenic kidney diseases; and BioArctic AB (publ) for new treatment. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

🌐 Visit Official Website ↗

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
1.1T
Enterprise Value
1.1T
Public Float
99.7
Broker Target
1240.4642
Shares Out
891.7M
Long Interest
100
Short Interest
0
Exchange
NYSE
Currency Code
USD
ISIN
US5324571083
Ex-Dividend
2026-08-14
Yield
0.57%
Dividend Rate
6.92
EPS
28.17
Index
S&P 500
Market
NYSE
Standard Lists
US500
Sector
Pharmaceuticals and BiotechnologyUS fundamentals
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

News And Alerts First

17 live alerts now opens the financials desk for LLY.

Start with the headline flow and alert tape first. Then drop straight into Financial Forecastist below for the revenue path, EPS shape, cash pressure and balance-sheet read while the catalyst context is still hot.
Live Alerts Data 2026-08-31 Forecastist Below
Read the alert tape first, then move into Financial Forecastist below. Use AI Expand on any catalyst card to open the AI explanation and results tables without losing the ticker context.
17 Alerts
Front Of Desk
Eli Lilly and Company has fresh filing flow live now, so the tape is framing the revenue, leverage and valuation story below.
22:28 Today's Alert Dow Jones Futures: Oil Prices Keep Rising On Iran News After Samsung Fans AI Fears 20:29 Today's Alert Why Eli Lilly (LLY) Stock Is Trading Up Today 20:17 Today's Alert Eli Lilly (LLY) After The China Verzenios Shift And The Valuation Debate
+14 more headlines waiting in Digested News
Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
6.92
Ex Divi
2026-08-14
Earnings Date
-
Net Debt
35.3B
Cash
7.2B
EPS
28.17
Net Income
20.6B
Revenue
72.2B
Enterprise Value
1.1T
Trailing PE
42.1931
Forward PE
32.7869
Price Sales TTM
14.6702
Price Book MRQ
33.9735
EV Revenue
15.1974
EV EBITDA
30.3188
Financial Forecastist

Improving financial engine

Revenue is accelerating +55.5% against the prior comparable period. Net margin is expanding by 15.7 pts. Net debt is building +7.9%.

Revenue +55.5% Net Income +168.0% FCF -287.8% Current Ratio 1.50x Forward Rev 21.7B
Improving
Quarter Revenue
19.8B
+55.5%
vs prior comparable quarter
Net Margin
+37.4%
+15.7 pts
profitability pulse
Free Cash Flow
3.0B
-287.8%
cash conversion
Net Debt / EBITDA
3.9x
+7.9%
lower is cleaner
Revenue Engine

Latest quarter printed 19.8B with the top line pushing higher against the last comparable period.

Profit Stack

Net income landed at 7.4B and the margin profile is broadening. That usually tells us whether operating leverage is finally kicking in.

Balance-Sheet Pressure

Cash sits near 5.1B while net debt is 38.2B. The leverage stack is moving the wrong way.

Quarterly Revenue Runway

Actual revenue bars, consensus revenue where available, plus the terminal model path.

Profit And Cash Conversion

Net income and free cash flow moving together is usually what separates genuine improvement from noise.

Balance-Sheet Pressure

Cash, net debt and liquidity tell us whether the business is strengthening or just surviving.

Annual Power Curve

Longer-cycle revenue and net income help frame whether the company is compounding or rolling over.
Q3 2025
Consensus
16.1B
Revenue Path
5.89
EPS / Earnings
Growth cue +4.0%
Q1 2026
Consensus
17.8B
Revenue Path
6.79
EPS / Earnings
Growth cue +1.0%
Q2 2026
Consensus
20.5B
Revenue Path
8.67
EPS / Earnings
Growth cue +0.4%
Q3 2026
Consensus
21.7B
Revenue Path
9.45
EPS / Earnings
Growth cue +0.3%
FY 2026
Consensus
85.4B
Revenue Path
36.16
EPS / Earnings
Growth cue +0.5%
FY 2027
Consensus
98.7B
Revenue Path
44.80
EPS / Earnings
Growth cue +0.2%

Quarterly Statement Tape

Last 6 Quarters
Period Revenue Net Income FCF Net Debt
Q1 2026 19.8B 7.4B 3.0B 38.2B
Q4 2025 19.3B 6.6B 677.9M 35.3B
Q3 2025 17.6B 5.6B 8.6B 32.7B
Q2 2025 15.6B 5.7B 1.3B 36.5B
Q1 2025 12.7B 2.8B -1.6B 35.4B
Q4 2024 13.5B 4.4B 726.6M 30.4B

Annual Financial Power

Last 5 Years
Period Revenue Net Income EBITDA FCF
FY 2025 65.2B 20.6B 27.9B 9.0B
FY 2024 45.0B 10.6B 15.2B 414.3M
FY 2023 34.1B 5.2B 8.6B -3.2B
FY 2022 28.5B 6.2B 8.7B 4.6B
FY 2021 28.3B 5.6B 8.0B 5.4B

Structure DNA

Market Structure DNA

Yield Compounder profile with trend runway open

Price is 90.3% through the 52-week range, +9.4% vs 50DMA and +19.3% vs 200DMA. 85.4% of the register is locked by institutions and insiders, leaving 14.6% free float. Capital rhythm reads quarterly with forward yield near 0.6% and payout around 22.0%.

Trend runway open Institutional gravity Reliable income rhythm As Of 2026-07-14
Yield Compounder
Structure Score
81.0 / 100
Yield Compounder
Trend Stack
+9.4% / +19.3%
vs 50DMA / 200DMA
52W Position
90.3%
auction position inside the yearly range
Ownership Lock
85.4%
85.2% institutions | 15.5% insiders
Pressure Pocket
1.1% short float
Short ratio 2.7x | monthly -4.5%
Capital Rhythm
Quarterly
Yield 0.6% | payout 22.0%
Trend Runway

Implied spot is 1,188.58 with the stock +9.4% vs 50DMA and +19.3% vs 200DMA. The tape is sitting 90.3% through the 52-week range, which frames the regime as trend runway open.

Ownership Register

Institutions hold about 85.2% and insiders about 15.5%, locking roughly 85.4% of the register and leaving 14.6% in free float. That reads as institutional gravity.

Pressure Pocket

Short pressure is running near 1.1% of float with short ratio 2.7x and monthly change -4.5%. That gives us a read on whether the tape is clean, crowded, or coiled.

Capital Rhythm

Dividend cadence reads quarterly with 4 event(s) in the last full year, a five-year average of 4.0, and stability score 100.0/100. Forward yield sits near 0.6% while payout is around 22.0%.

Structure Score

One-glance gauge for the current market-structure regime.

Pillar Radar

Trend, ownership, pressure, and capital rhythm mapped on one wheel.

Position And Float Balance

Shows whether the stock is extended, tightly held, or carrying capital-return support.

Dividend Cadence Tape

Historical dividend-event counts help reveal how dependable the income rhythm has been.

Dividend Cadence Ledger

Quarterly
Year Dividend Count Context
2026 3 Current partial year
2025 4 Full year
2024 4 Full year
2023 4 Full year
2022 4 Full year
2021 4 Full year
2020 4 Full year
2019 4 Full year

Structure Facts

Live Snapshot
Implied Spot
1,188.58
derived from market cap / shares
52W High
1,249.45
upper auction edge
52W Low
619.40
lower auction edge
Beta
0.51
volatility character
Shares Out
891.7M
fully diluted count
Shares Float
889.3M
tradable register
Shares Short
9.4M
borrowed stock
Short Ratio
2.7x
days-to-cover style read
Ex-Dividend
2026-08-14
31 day(s) to ex-date
Dividend Pay
2026-09-10
58 day(s) to pay date
Last Split
2:1
1997-10-16

Capital Radar

Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
-
Public Hands
-
Institutions
85.1742
Institutions As Of
2026-05-31
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
0
Sale Director Dealing
0
Purchase TR1
0
Sale TR1
0
Broker Coverage Rows
0
Institution Holders Tracked
40
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data · LLY · Last 30 Days

Short D · 12/26 EMA spread with 9 signal

Red histogram bars show short loading accelerating. Green bars show short covering accelerating. The two lines expose the crossover before the raw holder table does.

Short D waiting

Building LLY short-momentum read

Short D compares the ticker’s disclosed short-position momentum with its own signal line.

Short D—
Signal—
Momentum—

Declared Short Holders

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

News And Alerts First

The alert tape opens the door for LLY, and AI Charts sits just below.

Start with the headline flow and live catalyst tape first. Then move straight into AI Charts below for price reaction, AI targets, chart structure and catalyst beacons while the news context is still hot.
Live Tape Data 2026-08-31 AI Charts Below
Read the alert tape first, then move into AI Charts below. Use AI Expand on any catalyst card to open the AI explanation and results tables instantly.
17 Today
Catalyst Pulse
Eli Lilly and Company has fresh news flow live now, so the tape is framing the chart workspace below.
22:28 Today's Catalyst Dow Jones Futures: Oil Prices Keep Rising On Iran News After Samsung Fans AI Fears 20:29 Today's Catalyst Why Eli Lilly (LLY) Stock Is Trading Up Today 20:17 Today's Catalyst Eli Lilly (LLY) After The China Verzenios Shift And The Valuation Debate
+14 more headlines waiting in Digested News
AI Charts Studio
LLY Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2026-08-31 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
Desk Snapshot Member Login
AI AutoDetection Automatic bull / bear chart read
Detected market structure
Analysing selected range
Why this call
Waiting for sufficient price history.
Invalidation
—
Updates with the timeframe.
Bull caseCalculating upside confirmation.
Bear caseCalculating downside confirmation.
Indicators0
Technicals0
AI Forecast -5.58%
RSI Gauge
Price Change
AI Forecast